3,4-METHYLENEDIOXYAMPHETAMINE Latest Revision: August 16…4-METHYLENEDIOXYAMPHETAMINE.… ·...
Click here to load reader
Transcript of 3,4-METHYLENEDIOXYAMPHETAMINE Latest Revision: August 16…4-METHYLENEDIOXYAMPHETAMINE.… ·...
34-METHYLENEDIOXYAMPHETAMINE Latest Revision August 16 2005
1 SYNONYMS
CFR 34-Methylenedioxyamphetamine
CAS Base 4764-17-4
Hydrochloride 6292-91-7
Other Names 34-Methylenedioxy-α-methyl-β-phenethylamine
34-Methylenedioxyphenylisopropylamine
alpha-Methyl-13-benzodioxole-5-ethanamine
alpha-Methyl-13-benzodioxole-5-ethanamine
Tenamfetamine
Adam
Love
EA-1299
MDA
2 CHEMICAL AND PHYSICAL DATA
21 CHEMICAL DATA
Form Chemical Formula Molecular Weight Melting Point (degC)
Base C10H13NO2 1792 Oil
Hydrochloride C10H13NO2middotHCl 2157 187-88
22 SOLUBILITY
Form A C E H M W
Base S S S S I
Hydrochloride SS S I S S
Sulfate I I I S
A = acetone C = chloroform E = ether H = hexane M = methanol and W = water VS = very soluble FS =
freely soluble S = soluble PS = sparingly soluble SS = slightly soluble VSS = very slightly soluble and I =
insoluble
3 SCREENING TECHNIQUES
31 COLOR TESTS
REAGENT COLOR PRODUCED
Marquis Purple to black
32 THIN LAYER CHROMATOGRAPHY
Visualization
Acidified potassium permanganate solution
COMPOUND
Relative Rf
System
TLC 5
System
TLC 6
34-methylenedioxyethylamphetamine 11 12
34-methylenedioxyamphetamine 10 10
34-methylenedioxydimethylamphetamine 09 12
34-methylenedioxymethamphetamine 08 06
33 GAS CHROMATOGRAPHY
Method MDA-GCS1
Instrument Gas Chromatograph operated in split mode with FID
Column 5 phenyl95 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperatures Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
Samples are to be dissolved in 41 chloroform methanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 061 acetaminophen 124
methamphetamine 067 caffeine 134
safrole 080 methyl stearate 149
C14 089 cocaine 161
MDA 10 (417 min) methyl eicosanoate 162
MDMA 105 tetraphenylethylene 178
MDEA 109 heroin 189
MMDA 112
Method MDA-GCS2
Instrument Gas Chromatograph operated in split mode with FID
Column 50 phenyl50 methyl silicone 30 m x 025 mm x 025 microm film thickness
Carrier gas Hydrogen at 20 mLmin
Temperatures Injector 260degC
Detector 270degC
Oven program
1) 90oC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
Samples are to be dissolved in 41 chloroform methanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 062 acetaminophen 131
methamphetamine 066 caffeine 138
safrole 080 methyl stearate 130
C14 069 cocaine 158
MDA 10 (484 min) methyl eicosanoate 141
MDMA 103 tetraphenylethylene 177
MDEA 105 heroin 203
MMDA 107
Method MDA-GCS3
Instrument Gas Chromatograph operated in split mode with FID
Column 5 phenyl95 methyl silicone 5 m x 025 mm x 025microm film
thickness
Carrier gas Hydrogen
1) Initial pressure of 25 psi for 010 min
2) Ramp to 50 psi at 341 psimin
3) Hold final pressure for 077 min
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature
2) Ramp to 100degC at 10degCmin
3) Hold final temperature for 060 min
Injection Parameters Split Ratio = 501 1 microL injected
EZFlash Parameters
1) Time 0 sec = 100degC
2) Time 6 sec = 110degC
3) Time 50 sec = 310degC
4) Time 96 sec = 310degC
Samples are to be dissolved in 41 chloroformmethanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 073 acetaminophen 119
methamphetamine 077 caffeine 127
safrole 085 methyl stearate 128
C14 092 cocaine 150
MDA 10 (479 min) methyl eicosanoate 140
MDMA 104 tetraphenylethylene 169
MDEA 107 heroin 188
MMDA 108
Method MDA-GCS4
Instrument Gas Chromatograph operated in split mode with FID
Column 1 phenyl99 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
COMPOUND RRT COMPOUND RRT
amphetamine 056 acetaminophen 127
methamphetamine 175 caffeine 136
safrole 077 methyl stearate 163
C14 097 cocaine 170
MDA 10 (41 min) methyl eicosanoate 178
MDMA 106 tetraphenylethylene 189
MDEA 112 heroin 201
MMDA 115
4 SEPARATION TECHNIQUES
5 QUANTITATIVE PROCEDURE
51 GAS CHROMATOGRAPHY
Method MDA-GCQ1
Internal Standard Stock Solution
10 mgmL n-butylamphetamine HCl in chloroform
Standard Solution Preparation
Prepare a standard solution of MDA HCl at 04 mgmL in chloroform
Sample Preparation
Accurately weigh out 50 mg of sample into a 25 mL volumetric flask and dilute with water to the mark Take a
2 mL aliquot of the solution add 3 mL of IS and 2-3 mL of 05 M KOH Shake Separate layers and extract
twice more with 2-3 mL each time of chloroform Combine fractions ndash dry over sodium sulfate and dilute to
total volume of 10 mL Treat the standard in the same fashion as the sample prior to analysis
Instrument Gas Chromatograph operated in split mode with FID
Column DB-1 30 m x 025 mm x 025 m film thickness
Carrier gas Hydrogen at 13 mLmin
Make-Up gas Nitrogen at 400 mLmin
Temperatures Injector 230degC
Detector 280degC
Oven Program
1) 150degC initial temperature 2 min
2) Ramp to 190degC at 5degCmin
3) Hold final temperature for 10 min
Injection Parameters Split Ratio = 201 1microL injected
Typical Retention Time 34-MDA 213 min
N-Butylamphetamine HCl 189 min
Linear Range 006 mgmL to 20 mgmL
Repeatability RSD less than 20
Correlation Coefficient 09998
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT COMPOUND RRT
methylbenzylamine 040 salicylamide 089 caffeine 214
P2P 044 methyl paraben 089 antipyrine 230
amphetamine 045 penicillin 090 benzphetamine 235
nicotinic acid 048 phenmetrazine 093 diphenhydramine 246
phentermine 048 MDP-2-P 097 aminopyrine 260
methamphetamine 051 phendimetrazine 099 doxylamine 266
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
A = acetone C = chloroform E = ether H = hexane M = methanol and W = water VS = very soluble FS =
freely soluble S = soluble PS = sparingly soluble SS = slightly soluble VSS = very slightly soluble and I =
insoluble
3 SCREENING TECHNIQUES
31 COLOR TESTS
REAGENT COLOR PRODUCED
Marquis Purple to black
32 THIN LAYER CHROMATOGRAPHY
Visualization
Acidified potassium permanganate solution
COMPOUND
Relative Rf
System
TLC 5
System
TLC 6
34-methylenedioxyethylamphetamine 11 12
34-methylenedioxyamphetamine 10 10
34-methylenedioxydimethylamphetamine 09 12
34-methylenedioxymethamphetamine 08 06
33 GAS CHROMATOGRAPHY
Method MDA-GCS1
Instrument Gas Chromatograph operated in split mode with FID
Column 5 phenyl95 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperatures Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
Samples are to be dissolved in 41 chloroform methanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 061 acetaminophen 124
methamphetamine 067 caffeine 134
safrole 080 methyl stearate 149
C14 089 cocaine 161
MDA 10 (417 min) methyl eicosanoate 162
MDMA 105 tetraphenylethylene 178
MDEA 109 heroin 189
MMDA 112
Method MDA-GCS2
Instrument Gas Chromatograph operated in split mode with FID
Column 50 phenyl50 methyl silicone 30 m x 025 mm x 025 microm film thickness
Carrier gas Hydrogen at 20 mLmin
Temperatures Injector 260degC
Detector 270degC
Oven program
1) 90oC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
Samples are to be dissolved in 41 chloroform methanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 062 acetaminophen 131
methamphetamine 066 caffeine 138
safrole 080 methyl stearate 130
C14 069 cocaine 158
MDA 10 (484 min) methyl eicosanoate 141
MDMA 103 tetraphenylethylene 177
MDEA 105 heroin 203
MMDA 107
Method MDA-GCS3
Instrument Gas Chromatograph operated in split mode with FID
Column 5 phenyl95 methyl silicone 5 m x 025 mm x 025microm film
thickness
Carrier gas Hydrogen
1) Initial pressure of 25 psi for 010 min
2) Ramp to 50 psi at 341 psimin
3) Hold final pressure for 077 min
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature
2) Ramp to 100degC at 10degCmin
3) Hold final temperature for 060 min
Injection Parameters Split Ratio = 501 1 microL injected
EZFlash Parameters
1) Time 0 sec = 100degC
2) Time 6 sec = 110degC
3) Time 50 sec = 310degC
4) Time 96 sec = 310degC
Samples are to be dissolved in 41 chloroformmethanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 073 acetaminophen 119
methamphetamine 077 caffeine 127
safrole 085 methyl stearate 128
C14 092 cocaine 150
MDA 10 (479 min) methyl eicosanoate 140
MDMA 104 tetraphenylethylene 169
MDEA 107 heroin 188
MMDA 108
Method MDA-GCS4
Instrument Gas Chromatograph operated in split mode with FID
Column 1 phenyl99 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
COMPOUND RRT COMPOUND RRT
amphetamine 056 acetaminophen 127
methamphetamine 175 caffeine 136
safrole 077 methyl stearate 163
C14 097 cocaine 170
MDA 10 (41 min) methyl eicosanoate 178
MDMA 106 tetraphenylethylene 189
MDEA 112 heroin 201
MMDA 115
4 SEPARATION TECHNIQUES
5 QUANTITATIVE PROCEDURE
51 GAS CHROMATOGRAPHY
Method MDA-GCQ1
Internal Standard Stock Solution
10 mgmL n-butylamphetamine HCl in chloroform
Standard Solution Preparation
Prepare a standard solution of MDA HCl at 04 mgmL in chloroform
Sample Preparation
Accurately weigh out 50 mg of sample into a 25 mL volumetric flask and dilute with water to the mark Take a
2 mL aliquot of the solution add 3 mL of IS and 2-3 mL of 05 M KOH Shake Separate layers and extract
twice more with 2-3 mL each time of chloroform Combine fractions ndash dry over sodium sulfate and dilute to
total volume of 10 mL Treat the standard in the same fashion as the sample prior to analysis
Instrument Gas Chromatograph operated in split mode with FID
Column DB-1 30 m x 025 mm x 025 m film thickness
Carrier gas Hydrogen at 13 mLmin
Make-Up gas Nitrogen at 400 mLmin
Temperatures Injector 230degC
Detector 280degC
Oven Program
1) 150degC initial temperature 2 min
2) Ramp to 190degC at 5degCmin
3) Hold final temperature for 10 min
Injection Parameters Split Ratio = 201 1microL injected
Typical Retention Time 34-MDA 213 min
N-Butylamphetamine HCl 189 min
Linear Range 006 mgmL to 20 mgmL
Repeatability RSD less than 20
Correlation Coefficient 09998
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT COMPOUND RRT
methylbenzylamine 040 salicylamide 089 caffeine 214
P2P 044 methyl paraben 089 antipyrine 230
amphetamine 045 penicillin 090 benzphetamine 235
nicotinic acid 048 phenmetrazine 093 diphenhydramine 246
phentermine 048 MDP-2-P 097 aminopyrine 260
methamphetamine 051 phendimetrazine 099 doxylamine 266
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
33 GAS CHROMATOGRAPHY
Method MDA-GCS1
Instrument Gas Chromatograph operated in split mode with FID
Column 5 phenyl95 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperatures Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
Samples are to be dissolved in 41 chloroform methanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 061 acetaminophen 124
methamphetamine 067 caffeine 134
safrole 080 methyl stearate 149
C14 089 cocaine 161
MDA 10 (417 min) methyl eicosanoate 162
MDMA 105 tetraphenylethylene 178
MDEA 109 heroin 189
MMDA 112
Method MDA-GCS2
Instrument Gas Chromatograph operated in split mode with FID
Column 50 phenyl50 methyl silicone 30 m x 025 mm x 025 microm film thickness
Carrier gas Hydrogen at 20 mLmin
Temperatures Injector 260degC
Detector 270degC
Oven program
1) 90oC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
Samples are to be dissolved in 41 chloroform methanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 062 acetaminophen 131
methamphetamine 066 caffeine 138
safrole 080 methyl stearate 130
C14 069 cocaine 158
MDA 10 (484 min) methyl eicosanoate 141
MDMA 103 tetraphenylethylene 177
MDEA 105 heroin 203
MMDA 107
Method MDA-GCS3
Instrument Gas Chromatograph operated in split mode with FID
Column 5 phenyl95 methyl silicone 5 m x 025 mm x 025microm film
thickness
Carrier gas Hydrogen
1) Initial pressure of 25 psi for 010 min
2) Ramp to 50 psi at 341 psimin
3) Hold final pressure for 077 min
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature
2) Ramp to 100degC at 10degCmin
3) Hold final temperature for 060 min
Injection Parameters Split Ratio = 501 1 microL injected
EZFlash Parameters
1) Time 0 sec = 100degC
2) Time 6 sec = 110degC
3) Time 50 sec = 310degC
4) Time 96 sec = 310degC
Samples are to be dissolved in 41 chloroformmethanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 073 acetaminophen 119
methamphetamine 077 caffeine 127
safrole 085 methyl stearate 128
C14 092 cocaine 150
MDA 10 (479 min) methyl eicosanoate 140
MDMA 104 tetraphenylethylene 169
MDEA 107 heroin 188
MMDA 108
Method MDA-GCS4
Instrument Gas Chromatograph operated in split mode with FID
Column 1 phenyl99 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
COMPOUND RRT COMPOUND RRT
amphetamine 056 acetaminophen 127
methamphetamine 175 caffeine 136
safrole 077 methyl stearate 163
C14 097 cocaine 170
MDA 10 (41 min) methyl eicosanoate 178
MDMA 106 tetraphenylethylene 189
MDEA 112 heroin 201
MMDA 115
4 SEPARATION TECHNIQUES
5 QUANTITATIVE PROCEDURE
51 GAS CHROMATOGRAPHY
Method MDA-GCQ1
Internal Standard Stock Solution
10 mgmL n-butylamphetamine HCl in chloroform
Standard Solution Preparation
Prepare a standard solution of MDA HCl at 04 mgmL in chloroform
Sample Preparation
Accurately weigh out 50 mg of sample into a 25 mL volumetric flask and dilute with water to the mark Take a
2 mL aliquot of the solution add 3 mL of IS and 2-3 mL of 05 M KOH Shake Separate layers and extract
twice more with 2-3 mL each time of chloroform Combine fractions ndash dry over sodium sulfate and dilute to
total volume of 10 mL Treat the standard in the same fashion as the sample prior to analysis
Instrument Gas Chromatograph operated in split mode with FID
Column DB-1 30 m x 025 mm x 025 m film thickness
Carrier gas Hydrogen at 13 mLmin
Make-Up gas Nitrogen at 400 mLmin
Temperatures Injector 230degC
Detector 280degC
Oven Program
1) 150degC initial temperature 2 min
2) Ramp to 190degC at 5degCmin
3) Hold final temperature for 10 min
Injection Parameters Split Ratio = 201 1microL injected
Typical Retention Time 34-MDA 213 min
N-Butylamphetamine HCl 189 min
Linear Range 006 mgmL to 20 mgmL
Repeatability RSD less than 20
Correlation Coefficient 09998
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT COMPOUND RRT
methylbenzylamine 040 salicylamide 089 caffeine 214
P2P 044 methyl paraben 089 antipyrine 230
amphetamine 045 penicillin 090 benzphetamine 235
nicotinic acid 048 phenmetrazine 093 diphenhydramine 246
phentermine 048 MDP-2-P 097 aminopyrine 260
methamphetamine 051 phendimetrazine 099 doxylamine 266
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Method MDA-GCS2
Instrument Gas Chromatograph operated in split mode with FID
Column 50 phenyl50 methyl silicone 30 m x 025 mm x 025 microm film thickness
Carrier gas Hydrogen at 20 mLmin
Temperatures Injector 260degC
Detector 270degC
Oven program
1) 90oC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
Samples are to be dissolved in 41 chloroform methanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 062 acetaminophen 131
methamphetamine 066 caffeine 138
safrole 080 methyl stearate 130
C14 069 cocaine 158
MDA 10 (484 min) methyl eicosanoate 141
MDMA 103 tetraphenylethylene 177
MDEA 105 heroin 203
MMDA 107
Method MDA-GCS3
Instrument Gas Chromatograph operated in split mode with FID
Column 5 phenyl95 methyl silicone 5 m x 025 mm x 025microm film
thickness
Carrier gas Hydrogen
1) Initial pressure of 25 psi for 010 min
2) Ramp to 50 psi at 341 psimin
3) Hold final pressure for 077 min
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature
2) Ramp to 100degC at 10degCmin
3) Hold final temperature for 060 min
Injection Parameters Split Ratio = 501 1 microL injected
EZFlash Parameters
1) Time 0 sec = 100degC
2) Time 6 sec = 110degC
3) Time 50 sec = 310degC
4) Time 96 sec = 310degC
Samples are to be dissolved in 41 chloroformmethanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 073 acetaminophen 119
methamphetamine 077 caffeine 127
safrole 085 methyl stearate 128
C14 092 cocaine 150
MDA 10 (479 min) methyl eicosanoate 140
MDMA 104 tetraphenylethylene 169
MDEA 107 heroin 188
MMDA 108
Method MDA-GCS4
Instrument Gas Chromatograph operated in split mode with FID
Column 1 phenyl99 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
COMPOUND RRT COMPOUND RRT
amphetamine 056 acetaminophen 127
methamphetamine 175 caffeine 136
safrole 077 methyl stearate 163
C14 097 cocaine 170
MDA 10 (41 min) methyl eicosanoate 178
MDMA 106 tetraphenylethylene 189
MDEA 112 heroin 201
MMDA 115
4 SEPARATION TECHNIQUES
5 QUANTITATIVE PROCEDURE
51 GAS CHROMATOGRAPHY
Method MDA-GCQ1
Internal Standard Stock Solution
10 mgmL n-butylamphetamine HCl in chloroform
Standard Solution Preparation
Prepare a standard solution of MDA HCl at 04 mgmL in chloroform
Sample Preparation
Accurately weigh out 50 mg of sample into a 25 mL volumetric flask and dilute with water to the mark Take a
2 mL aliquot of the solution add 3 mL of IS and 2-3 mL of 05 M KOH Shake Separate layers and extract
twice more with 2-3 mL each time of chloroform Combine fractions ndash dry over sodium sulfate and dilute to
total volume of 10 mL Treat the standard in the same fashion as the sample prior to analysis
Instrument Gas Chromatograph operated in split mode with FID
Column DB-1 30 m x 025 mm x 025 m film thickness
Carrier gas Hydrogen at 13 mLmin
Make-Up gas Nitrogen at 400 mLmin
Temperatures Injector 230degC
Detector 280degC
Oven Program
1) 150degC initial temperature 2 min
2) Ramp to 190degC at 5degCmin
3) Hold final temperature for 10 min
Injection Parameters Split Ratio = 201 1microL injected
Typical Retention Time 34-MDA 213 min
N-Butylamphetamine HCl 189 min
Linear Range 006 mgmL to 20 mgmL
Repeatability RSD less than 20
Correlation Coefficient 09998
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT COMPOUND RRT
methylbenzylamine 040 salicylamide 089 caffeine 214
P2P 044 methyl paraben 089 antipyrine 230
amphetamine 045 penicillin 090 benzphetamine 235
nicotinic acid 048 phenmetrazine 093 diphenhydramine 246
phentermine 048 MDP-2-P 097 aminopyrine 260
methamphetamine 051 phendimetrazine 099 doxylamine 266
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature
2) Ramp to 100degC at 10degCmin
3) Hold final temperature for 060 min
Injection Parameters Split Ratio = 501 1 microL injected
EZFlash Parameters
1) Time 0 sec = 100degC
2) Time 6 sec = 110degC
3) Time 50 sec = 310degC
4) Time 96 sec = 310degC
Samples are to be dissolved in 41 chloroformmethanol and filtered
COMPOUND RRT COMPOUND RRT
amphetamine 073 acetaminophen 119
methamphetamine 077 caffeine 127
safrole 085 methyl stearate 128
C14 092 cocaine 150
MDA 10 (479 min) methyl eicosanoate 140
MDMA 104 tetraphenylethylene 169
MDEA 107 heroin 188
MMDA 108
Method MDA-GCS4
Instrument Gas Chromatograph operated in split mode with FID
Column 1 phenyl99 methyl silicone 30 m x 025 mm x 025 microm film
thickness
Carrier gas Hydrogen at 20 mLmin
Temperature Injector 260degC
Detector 270degC
Oven program
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
COMPOUND RRT COMPOUND RRT
amphetamine 056 acetaminophen 127
methamphetamine 175 caffeine 136
safrole 077 methyl stearate 163
C14 097 cocaine 170
MDA 10 (41 min) methyl eicosanoate 178
MDMA 106 tetraphenylethylene 189
MDEA 112 heroin 201
MMDA 115
4 SEPARATION TECHNIQUES
5 QUANTITATIVE PROCEDURE
51 GAS CHROMATOGRAPHY
Method MDA-GCQ1
Internal Standard Stock Solution
10 mgmL n-butylamphetamine HCl in chloroform
Standard Solution Preparation
Prepare a standard solution of MDA HCl at 04 mgmL in chloroform
Sample Preparation
Accurately weigh out 50 mg of sample into a 25 mL volumetric flask and dilute with water to the mark Take a
2 mL aliquot of the solution add 3 mL of IS and 2-3 mL of 05 M KOH Shake Separate layers and extract
twice more with 2-3 mL each time of chloroform Combine fractions ndash dry over sodium sulfate and dilute to
total volume of 10 mL Treat the standard in the same fashion as the sample prior to analysis
Instrument Gas Chromatograph operated in split mode with FID
Column DB-1 30 m x 025 mm x 025 m film thickness
Carrier gas Hydrogen at 13 mLmin
Make-Up gas Nitrogen at 400 mLmin
Temperatures Injector 230degC
Detector 280degC
Oven Program
1) 150degC initial temperature 2 min
2) Ramp to 190degC at 5degCmin
3) Hold final temperature for 10 min
Injection Parameters Split Ratio = 201 1microL injected
Typical Retention Time 34-MDA 213 min
N-Butylamphetamine HCl 189 min
Linear Range 006 mgmL to 20 mgmL
Repeatability RSD less than 20
Correlation Coefficient 09998
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT COMPOUND RRT
methylbenzylamine 040 salicylamide 089 caffeine 214
P2P 044 methyl paraben 089 antipyrine 230
amphetamine 045 penicillin 090 benzphetamine 235
nicotinic acid 048 phenmetrazine 093 diphenhydramine 246
phentermine 048 MDP-2-P 097 aminopyrine 260
methamphetamine 051 phendimetrazine 099 doxylamine 266
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
1) 90degC initial temperature for 10 min
2) Ramp to 295degC at 30degmin
3) Hold final temperature for 26 min
Injection Parameters Split Ratio = 501 1 microL injected
COMPOUND RRT COMPOUND RRT
amphetamine 056 acetaminophen 127
methamphetamine 175 caffeine 136
safrole 077 methyl stearate 163
C14 097 cocaine 170
MDA 10 (41 min) methyl eicosanoate 178
MDMA 106 tetraphenylethylene 189
MDEA 112 heroin 201
MMDA 115
4 SEPARATION TECHNIQUES
5 QUANTITATIVE PROCEDURE
51 GAS CHROMATOGRAPHY
Method MDA-GCQ1
Internal Standard Stock Solution
10 mgmL n-butylamphetamine HCl in chloroform
Standard Solution Preparation
Prepare a standard solution of MDA HCl at 04 mgmL in chloroform
Sample Preparation
Accurately weigh out 50 mg of sample into a 25 mL volumetric flask and dilute with water to the mark Take a
2 mL aliquot of the solution add 3 mL of IS and 2-3 mL of 05 M KOH Shake Separate layers and extract
twice more with 2-3 mL each time of chloroform Combine fractions ndash dry over sodium sulfate and dilute to
total volume of 10 mL Treat the standard in the same fashion as the sample prior to analysis
Instrument Gas Chromatograph operated in split mode with FID
Column DB-1 30 m x 025 mm x 025 m film thickness
Carrier gas Hydrogen at 13 mLmin
Make-Up gas Nitrogen at 400 mLmin
Temperatures Injector 230degC
Detector 280degC
Oven Program
1) 150degC initial temperature 2 min
2) Ramp to 190degC at 5degCmin
3) Hold final temperature for 10 min
Injection Parameters Split Ratio = 201 1microL injected
Typical Retention Time 34-MDA 213 min
N-Butylamphetamine HCl 189 min
Linear Range 006 mgmL to 20 mgmL
Repeatability RSD less than 20
Correlation Coefficient 09998
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT COMPOUND RRT
methylbenzylamine 040 salicylamide 089 caffeine 214
P2P 044 methyl paraben 089 antipyrine 230
amphetamine 045 penicillin 090 benzphetamine 235
nicotinic acid 048 phenmetrazine 093 diphenhydramine 246
phentermine 048 MDP-2-P 097 aminopyrine 260
methamphetamine 051 phendimetrazine 099 doxylamine 266
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Sample Preparation
Accurately weigh out 50 mg of sample into a 25 mL volumetric flask and dilute with water to the mark Take a
2 mL aliquot of the solution add 3 mL of IS and 2-3 mL of 05 M KOH Shake Separate layers and extract
twice more with 2-3 mL each time of chloroform Combine fractions ndash dry over sodium sulfate and dilute to
total volume of 10 mL Treat the standard in the same fashion as the sample prior to analysis
Instrument Gas Chromatograph operated in split mode with FID
Column DB-1 30 m x 025 mm x 025 m film thickness
Carrier gas Hydrogen at 13 mLmin
Make-Up gas Nitrogen at 400 mLmin
Temperatures Injector 230degC
Detector 280degC
Oven Program
1) 150degC initial temperature 2 min
2) Ramp to 190degC at 5degCmin
3) Hold final temperature for 10 min
Injection Parameters Split Ratio = 201 1microL injected
Typical Retention Time 34-MDA 213 min
N-Butylamphetamine HCl 189 min
Linear Range 006 mgmL to 20 mgmL
Repeatability RSD less than 20
Correlation Coefficient 09998
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT COMPOUND RRT
methylbenzylamine 040 salicylamide 089 caffeine 214
P2P 044 methyl paraben 089 antipyrine 230
amphetamine 045 penicillin 090 benzphetamine 235
nicotinic acid 048 phenmetrazine 093 diphenhydramine 246
phentermine 048 MDP-2-P 097 aminopyrine 260
methamphetamine 051 phendimetrazine 099 doxylamine 266
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
COMPOUND RRT COMPOUND RRT COMPOUND RRT
fenfluramine 055 MDA 10 (213 min) phthalic acid 282
ethylamphetamine 056 MDMA 115 palmitic acid 282
dimethylamphetamine 058 aminorex 121 dipyrone 289
safrole 063 methyl aminorex 121 procaine 306
salicylic acid 064 MDEA 130 eicosane 307
cathine 068 ibuprofen 143 dextromethorphan 359
phenylpropanolamine 068 MBDB 145 strychnine 365
methcathinone 069 hexadecane 147 amitriptyline 384
nicotinamide 071 guaifenesin 150 scopolamine 427
chlorpheniramine 075 acetaminophen 155 tetracosane 458
chloroephedrine 076 MMDA 159 chlordiazepoxide 496
pseudoephedrine 076 phenacetin 162 quinine 602
ephedrine 078 chloromdma 171
butylamphetamine 089 methylphenidate 187
52 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Method MDA-LCQ1
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 10 mgmL using water Filter
with a 045-microm filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with water If necessary dilute the
sample so the final concentration approximates the standard concentration or falls within the linear range Filter
sample with a 045-microm filter
Instrument High performance liquid chromatograph equipped with diode array
Column 5 microm ODS 40 mm x 125 mm
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Flow 10 mLmin
Injection Volume 1 microL
Buffer 4000 mL distilled water 30 mL phosphoric acid 10 g sodium
hydroxide and 80 mL hexylamine at pH 25
Mobile Phase Buffer acetonitrile 8515 with gradient to 6040 over 6 min
Typical Retention Time 34-MDA 163 min
Linear Range 01338 - 428 mgmL
Repeatability RSD less than 02
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT
Nicotinamide 062
MDA 100
MDMA 116
MDEA 141
Method MDA-LCQ2
Standard Solution Preparation
Prepare a standard solution of MDA HCl at approximately 05 mgmL using water buffer or methanol
Sample Preparation
Accurately weigh an amount of sample into an appropriate volumetric or Erlenmeyer flask and dilute so that the
final MDA HCl concentration is approximately that of the standard solution
Instrument High performance liquid chromatograph equipped with diode array
Column 5 Phenomenex Luna 150 mm x 32 mm at 35 C
Detector UV 210 nm
Flow 10 mLmin
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Injection Volume 5 microL
Buffer 4000 mL distilled water 225 mL phosphoric acid adjust to pH 22-23
with triethanolamine (approx 22 mL)
Mobile Phase Bufferacetonitrile 9010
Typical Retention Time 34-MDA 98 min
Linear Range 005 mgmL - 2 mgmL
Repeatability RSD less than 05
Correlation Coefficient 09999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
phenylpropanolamine 065 methyl aminorex 109
methyl benzylamine 067 phentermine 110
cathine 068 chloroephedrine 111
doxylamine 074 ethylamphetamine 113
dipyrone 075 MDP-2-P 113
ephedrine 077 lidocaine 115
methcathinone 079 caffeine 116
pseudoephedrine 079 MDEA 122
amphetamine 090 phenyl-2-naphthalene 122
theophylline 094 phthalic acid 122
methapyrilene 096 strychnine 123
phenmetrazine 096 MMDA 126
methamphetamine 098 MBDB 134
phendimetrazine 098 salicylamide 137
scopolamine 099 acetaminophen 139
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
COMPOUND RRT COMPOUND RRT
MDA 100 (98 min) chloro-mdma 147
quinine 103 methylphenidate 148
saccharin 103 glycerol glycolate 159
dimethylamphetamine 104 chlorpheniramine 167
MDMA 108 aspirin 195
chlordiazepoxide 201
53 CAPILLARY ELECTROPHORESIS
Method MDA-CEQ1
Internal Standard Stock Solution
050 mgmL n-butylamphetamine HCl in 50 mM sodium phosphate at pH 70
Standard Solution Preparation
Accurately weigh and prepare a standard solution of MDA HCl at approximately 08 mgmL using the internal
standard stock solution Filter with 045 micron filter
Sample Preparation
Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution
If necessary dilute the sample so the final concentration approximates the standard concentration or falls within
the linear range Filter sample with 045-micron filter
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Mode Cyclodextrin system analysis
Column 49 cm x 52 microm fused silica capillary
Run Buffer 10 mM gamma-highly sulfated cyclodextrin in 50 mM sodium
phosphate at pH 70
Detector UV 210 nm
Voltage 12 kV
Temperature 30degC air cooled
Injection 1 s hydrodynamic at 50 mbars
Run Time 17 min
Rinse Time 20 min
Linear Range 002 - 100 mgmL
Repeatability RSD of area less than 15
Correlation Coefficient 0999
Accuracy Error less than 5
COMPOUND RRT COMPOUND RRT
d-methamphetamine 083 l-pseudoephedrine 123
d-ephedrine 093 MDMA 125
MDA 10 (883 min) l-ephedrine 136
cathine 106 MDEA 140
l-methamphetamine 111 MDMA 148
d-amphetamine 118 l-norephedrine 165
d-norephedrine 118 l-amphetamine 168
d-pseudoephedrine 121 MDA 170
MDEA 186
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Method MDA-CEQ2
Internal Standard Stock Solution
10 mgmL n-Butylamphetamine HCl in 38 mM phosphate buffer (pH 25)
Standard Solution Preparation
Weigh an appropriate amount of standard MDA HCl into a volumetric flask to obtain a final concentration of
approximately 008 mgmL Pipette an appropriate amount of internal standard solution to obtain a final
concentration of 01 mgmL Dilute to volume with injection solvent Filter approximately 10 mL of solution
with regenerated cellulose 045 microm 25mm filter into a 20 mL glass vial (Agilent part number 5182-0567)
Make sure there are no air bubbles on bottom of glass vial Cap vial with polypropylene cap (Agilent part
number 5182-9697)
Sample Preparation
Weigh an appropriate amount of sample into a volumetric flask so that the final phenethylamine concentration
is approximately that of the standard solution Pipette appropriate amount of internal standard solution to obtain
a final concentration of 01 mgmL Dilute to volume with injection solvent Sonicate for 15 minutes Filter
approximately 10 mL of solution with regenerated cellulose 045 m 25mm filter into a 20 mL glass vial
(Agilent part number 5182-0567) Make sure there are no air bubbles on bottom of glass vial Cap vial with
polypropylene cap (Agilent part number 5182-9697)
Mode HP 3D instrument operated in CE mode
Cyclodextrin system analysis
Column 50 microm id x 322 cm
(237 cm length to detector)
Run Buffer Celixir Reagent B pH 25 (MicroSolv CE)
Detector Diode-array
Voltage 10 kV
Temperature 15degC
Injection 50 mbar x 2 s followed by water at 35 mbar
Run Time 6 min
Rinse Time 2 min
Linear Range 002 ndash 100 mgmL
Repeatability RSD lt16
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Correlation Coefficient 10
Accuracy Error less than 32
COMPOUND RRT COMPOUND RRT
doxylamine 0765 ephedrine 0932
chlorpheniramine 0784 phenylephrine 0951
quinine 0804 MDEA 0961
-phenethylamine 0807 ketamine 0962
chlorquinine 0812 phenyltoxolamine 0971
nicotinamide 0836 n-butylamphetamine 10 (46 min)
amphetamine 0868 dextromethorphan 100
methamphetamine 0883 lidocaine 103
procaine 0883 benzocaine 125
MDA 0900 acetaminophen 211
norpseudoephedrine 0906 caffeine 214
MDMA 0914 guaifenesin 214
norephedrine 0917 P2P 224
pseudoephedrine 0919 DMSO (neutral marker) 240
tetracaine 0927 aspirin 271
54 NUCLEAR MAGNETIC RESONANCE
Method NMR-1-1
Solvents Deuterium Oxide (D2O) containing DSS or TSP for 0 PPM reference
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Internal Standard Stock Solution (ISSS) 5 mgmL Maleic Acid (accurately weighed) in deuterium oxide (D2O)
containing DSS or TSP for 0 ppm reference
Sample Preparation Accurately weigh an amount of sample usually 10-30 mg into a capped test tube and
accurately add a volume normally 10 mL of the ISSS Vortex the sample for several seconds If insolubles
are present add 10 mL D2O (not containing maleic acid or the reference compound) vortex and sonicate 15
minutes Vortex the sample and filter if necessary Place in NMR sample tube
Instrument Varian Mercury 400 MHz with proton detection probe NMR Spectrometer
Pulse Width 10 micros or 90deg (whichever is less)
Spectral Width (SW) at least containing ndash3 ppm through 13 ppm
Number of Scans multiple of 4 (greater to enhance SN)
Delay between Pulses 45 s
Shimming automatic gradient shimming of Z1-4 shims
Total run timesample 6 min (NT = 4) -14 min (NT = 16)
Uniformity within spectral width 03 RSD (-06 to 114 PPM)
Run Time 6 min
Linear Range 06 mgmL - 67 mgmL
Repeatability lt4
Correlation Coefficient 10
Accuracy lt3
6 QUALITATIVE DATA
See spectra on the following pages for Mass Spectrometry FT-IR Vapor Phase IR FT-Raman and Nuclear
Magnetic Resonance
7 REFERENCES
Coates J and Reffner J Visualization of Micro-ATR Infrared Spectroscopy Spectroscopy Vol 14 4
April 1999
Clarke EGC Isolation and Identification of Drugs 2nd Edition The Pharmaceutical Press 1986
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Galichat Laurent Y Clarkersquos Analysis of Drugs and Poisons Volume 2 p 1256 Pharmaceutical Press 2004
Budavari S The Merck Index 13th Edition Merck and Co Inc 2001
8 ADDITIONAL RESOURCES
Forendex
Wikipedia
Optical isomers standards for these compounds were unavailable
No Data Available
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
Mass Spectrum (EI) 34-Methylenedioxyamphetamine HCl Lot A150B
FTIR (One bounce - ATR) 34-Methylenedioxyamphetmaine HCl Lot A150B
4 cm-1
resolution 32 scans
17
80863103337
123768
148695
290079
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500 4000
Wavenumbers (cm-1)
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
FTIR (One bounce ndash ATR) 34-Methylenedioxyamphetamine sulfate Lot X-19LDS
4 cm-1
resolution 32 scans
GCIRD 34-Methylenedioxyamphetamine Lot A150B
4 cm-1
resolution 2 mgmL in chloroform
45312
62064
102923
108235
125805
148277
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
T
500 1000 1500 2000 2500 3000 3500
Wavenumbers (cm-1)
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
FT-RAMAN 34-Methylenedioxyamphetamine HCl Lot A150B
4 cm-1
resolution 32 scans
FT-RAMAN 34-Methylenedioxyamphetamine sulfate Lot X-19-LDS
4 cm-1
resolution 32 scans
DEA
52
93
81
13
12
56
8
13
75
3
29
32
4
30
83
6
05
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
DEA
71
32
81
13
97
48
29
28
3
30
67
3
02
04
06
08
10
12
14
16
18
20
22
24
26
28
30
Int
500 1000 1500 2000 2500 3000 3500
Raman shift (cm-1)
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard
1H NMR 34-Methylenedioxyamphetamine HCl Lot A150B
deuterium oxide maleic acid as internal standard 400 MHz
ppm 688 (d J=79 Hz 1 H) 683 (d J=14 Hz 1 H) 679 (dd J=79 14
Hz 1 H) 596 (s 2 H) 359 (tq J=72 67 Hz 1 H) 287 (d J=72 Hz 2
H) 132 (d J=67 Hz 3 H)
13
C NMR 34 Methylenedioxyamphetamine HCl Lot A 150B
deuterium oxide maleic acid as internal standard